LUND, Sweden, Aug. 25, 2020 /PRNewswire/ -- Alligator
Bioscience (Nasdaq Stockholm: ATORX) invites to a virtual
R&D Day on August 27 at
2:00 p.m. - 3:00 p.m., in which CEO
Per Norlén and COO Malin Carlsson will give an update on the status
and latest development steps in the company's clinical pipeline -
focusing on the drug candidates mitazalimab, ATOR-1015 and
ATOR-1017. Guest speaker, Professor Ignacio
Melero at University of Navarra,
will give his view on 4-1BB, the target for ATOR-1017.
Program (approximate times):
2:00 p.m. Company
introduction and clinical development update ATOR-1015 and
mitazalimab
Speaker: Per Norlén, CEO
2:15 p.m. ATOR-1017
- Concept and latest news
Speaker: Malin Carlsson, COO
2:30 p.m. 4-1BB - An
attractive target for cancer immunotherapy
Speaker: Professor Ignacio
Melero, University of Navarra,
Pamplona, Spain
2:45 p.m. Q&A
session
3:00 p.m.
Conclusions
Presentations will be in English and can be followed live
via Alligator Bioscience's YouTube channel
https://youtu.be/eBfz0q77p78. A recording will also be made
available on the Alligator web site after the event,
www.alligatorbioscience.com. Questions to the speakers can be sent
to red@biostock.se.
For further information, please contact:
Cecilia Hofvander, Director
Investor Relations & Communications
Phone +46 46 540 82 06
E-mail: cecilia.hofvander@alligatorbioscience.com
About Alligator Bioscience
Alligator Bioscience AB is a clinical-stage biotechnology
company developing tumor-directed immuno-oncology antibody drugs.
Alligator's pipeline includes six lead clinical and preclinical
drug candidates: Mitazalimab, ATOR-1015, ATOR-1017, ALG.APV-527
(co-developed with Aptevo Therapeutics Inc.) and AC101 (in clinical
development by Shanghai Henlius Biotech Inc.). Alligator's shares
are listed on Nasdaq Stockholm (ATORX). The Company is
headquartered in Lund, Sweden. For
more information, please visit www.alligatorbioscience.com.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/alligator-bioscience/r/alligator-bioscience-virtual-r-d-day---august-27--2020,c3180719
The following files are available for download:
https://mb.cision.com/Main/12681/3180719/1296981.pdf
|
Alligator Bioscience
Virtual R&D Day - August 27, 2020
|
View original
content:http://www.prnewswire.com/news-releases/alligator-bioscience-virtual-rd-day---august-27-2020-301117691.html
SOURCE Alligator Bioscience